BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
Argus Health
US Department of Justice
Fish and Richardson
Johnson and Johnson
Boehringer Ingelheim

Generated: September 22, 2017

DrugPatentWatch Database Preview

SYNERCID Drug Profile

« Back to Dashboard

What is the patent landscape for Synercid, and when can generic versions of Synercid launch?

Synercid is a drug marketed by King Pharms and is included in one NDA.

The generic ingredient in SYNERCID is dalfopristin; quinupristin. One supplier is listed for this compound. Additional details are available on the dalfopristin; quinupristin profile page.

Summary for Tradename: SYNERCID

Suppliers / Packagers: see list1
Bulk Api Vendors: see list2
Clinical Trials: see list1
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:SYNERCID at DailyMed

Pharmacology for Tradename: SYNERCID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
King Pharms
dalfopristin; quinupristin
INJECTABLE;IV (INFUSION)050748-001Sep 21, 1999RXYesYes► Subscribe► Subscribe► Subscribe
King Pharms
dalfopristin; quinupristin
INJECTABLE;IV (INFUSION)050748-002Aug 24, 2000DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Queensland Health
Johnson and Johnson
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus